Illustrative image – not actual.Mukesh Ambani's Reliance Pharmaceuticals (RPL), a wholly-owned subsidiary of Reliance Life Sciences (RLS) is planning to set up a generic drug manufacturing plant at the special economic zone at Jamnagar in Gujarat with an investment of around Rs.1,000 crore
The new plant, which will be in compliance with US and European drug quality regulations, will have a capacity of 700 tpa of capsules, tablets and liquid oral drugs.
Construction work on the proposed plant is expected to start by end-2007 and is scheduled for completion within 18 months from the date of commencement.
